Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

Carpio C, Iacoboni G, Villacampa G, Catala E, et al. Selection process and causes of non-eligibility for CD19 CAR-T cell therapy in patients with relapsed/refractory aggressive B-cell non-Hodgkin lymphoma in a European center. Leuk Lymphoma 2021 Apr 24:1-4. doi: 10.1080/10428194.2021.1913141.
PMID: 33899648


Privacy Policy